EarningsQ3 2024 Earnings Report

Rhythm Pharmaceuticals (RYTM) Q3 2024 Earnings Report

1 Followers

MX:RYTM Q3 2024 EPS Results

Actual EPS-$13.21

Consensus EPS-$14.57

Beat/MissBeat by +$1.36

One Year Ago EPS-$13.75

Actual Revenue$601.69M

Expected Revenue$588.51M

Beat/MissBeat by +$13.17M

YoY Revenue Growth+47.76%

QuarterQ3 2024

Date11/05/2024

TimeAfter Close

Conference CallTuesday, November 5, 2024

MX:RYTM Upcoming Earnings

Rhythm Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

MX:RYTM Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-13.08 / -	-14.838	―
Aug 04, 2026	2026 (Q2)	-14.60 / -13.21	-13.571	2.67% (+0.36)
May 05, 2026	2026 (Q1)	-14.87 / -15.02	-14.657	-2.47% (-0.36)
Feb 26, 2026	2025 (Q4)	-14.57 / -13.21	-13.029	-1.39% (-0.18)
Nov 04, 2025	2025 (Q3)	-12.81 / -14.84	-13.21	-12.33% (-1.63)
Aug 05, 2025	2025 (Q2)	-12.12 / -13.57	-9.952	-36.36% (-3.62)
May 07, 2025	2025 (Q1)	-12.56 / -14.66	-42.524	65.53% (+27.87)
Feb 26, 2025	2024 (Q4)	-12.56 / -13.03	-12.667	-2.86% (-0.36)
Nov 05, 2024	2024 (Q3)	-14.57 / -13.21	-13.752	3.95% (+0.54)
Aug 06, 2024	2024 (Q2)	-12.83 / -9.95	-14.838	32.93% (+4.89)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed